FTO and neoplasm: Saikosaponin D, GNPIPP12MA and ZLD115a, three novel FTO inhibitors, exhibit exceptional efficacy in inhibiting FTO’s activity on MYC mRNA, downregulating aerobic glycolysis and suppressing tumor progression [105, 106, 115].